EPITOPE SUMMARY | |
---|---|
LMLGEFLKL is a linear peptidic epitope (epitope ID ). The epitope is an analog of: LTLGEFLKL from Homo sapiens (human) Baculoviral IAP repeat-containing protein 5. The epitope is an analog of: LTLGEFLKL from Homo sapiens (human) Isoform 5 of Baculoviral IAP repeat-containing protein 5. The epitope is a mimotope of: LTLGEFLKL from Homo sapiens (human) survivin-beta [Homo sapiens]. The epitope is an analog of: LTLGEFLKL from Homo sapiens (human) baculoviral IAP repeat-containing protein 5 isoform 1. The epitope is an analog of: ELTGEFLKL from Homo sapiens (human) Baculoviral IAP repeat-containing protein 5. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays and MHC ligand assays. |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
IFNg release | / |
cytotoxicity | / |
qualitative binding | / |
TNFa release | / |
activation | / |
IL-4 release | / |
degranulation | / |
GM-CSF release | / |
granzyme B release | / |
IL-10 release | / |
IL-2 release | / |
survival from challenge after adoptive transfer | / |
tumor burden after challenge after adoptive transfer | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |